Degloving Injury (Lower Extremity)

Understanding Degloving Injuries (Lower Extremity)

A degloving injury—medically termed an avulsion injury—represents one of the most severe forms of soft tissue trauma encountered in reconstructive surgery. In the lower extremity, this injury occurs when a significant shearing force causes the skin and subcutaneous tissue to be detached from the underlying fascia, muscles, and bone. This separation disrupts the perforating blood vessels, leading to ischemia, tissue necrosis, and often complex orthopedic complications.

Given the ICD-10 classification S71.112A, these injuries are typically associated with high-energy trauma, such as motor vehicle accidents, pedestrian-vehicle collisions, or industrial machinery entrapment. Because the lower extremity relies on a delicate network of vascular supply, a degloving event is not merely a surface wound; it is a systemic surgical emergency that requires immediate intervention by a plastic and reconstructive surgery team.

Pathophysiology, Etiology, and Risk Factors

The Mechanism of Injury

The pathophysiology of a degloving injury is rooted in the mechanical failure of the subdermal plexus. When a tangential force is applied to the limb, the skin and subcutaneous fat slide over the deep fascia. If the force exceeds the tensile strength of the perforating vessels, these vessels rupture.

• Closed Degloving (Morel-Lavallée Lesion): The skin remains intact, but a potential space is created between the fascia and the subcutaneous tissue, which fills with blood, lymph, and necrotic fat.
• Open Degloving: The skin is avulsed, exposing the underlying muscle, bone, and neurovascular bundles.

Etiology and Risk Factors

The primary etiology is high-energy blunt trauma. Risk factors that exacerbate the severity of the injury include:

Signs, Symptoms, and Clinical Presentation

The clinical presentation of a degloving injury is often dramatic and requires a high index of suspicion, especially in cases of closed injuries (Morel-Lavallée lesions) where the surface may appear deceptively normal.

Key Indicators:

1. Skin Discoloration: Initial pallor followed by cyanosis or ecchymosis as the vascular supply fails.
2. Fluctuance: In closed injuries, a palpable, mobile mass that shifts under the skin.
3. Loss of Sensation: Indicates potential nerve damage or severe ischemic neuropathy.
4. Exposed Subcutaneous Tissue: In open injuries, the "degloved" flap may appear pale or gray, signaling immediate necrosis.
5. Crepitus: May indicate subcutaneous emphysema if a fracture is present.

Standard Diagnostic Evaluation & Workup

Diagnostic protocols prioritize ruling out life-threatening systemic trauma before addressing the local injury.

Imaging Modalities

• Radiography (X-ray): Essential to rule out underlying fractures (ICD-10 S71 implies skin/subcutaneous involvement, but fractures are common).
• Ultrasound: The gold standard for identifying Morel-Lavallée lesions. It reveals the fluid-filled collection between the subcutaneous tissue and deep fascia.
• MRI: The definitive diagnostic tool for assessing the extent of soft tissue involvement, muscle necrosis, and the integrity of the deep fascia.
• CT Angiography (CTA): Critical if there is suspicion of injury to the major arteries (e.g., popliteal or tibial arteries).

Laboratory Assays

• Complete Blood Count (CBC): To monitor for acute blood loss.
• Inflammatory Markers (CRP/ESR): Used to baseline systemic response to trauma.
• Wound Cultures: Mandatory in open degloving injuries to detect early bacterial colonization.

Therapeutic Interventions

Management of a lower extremity degloving injury is a multidisciplinary effort involving trauma surgeons, orthopedists, and plastic surgeons.

Surgical Management

1. Debridement: The cornerstone of treatment. All non-viable, necrotic, or contaminated tissue must be excised.
2. Flap Management: In some cases, the degloved skin can be harvested as a full-thickness skin graft, defatted, and reapplied. If the tissue is too damaged, local or free flaps (tissue transfer) are utilized.
3. Negative Pressure Wound Therapy (NPWT): Also known as a VAC (Vacuum Assisted Closure), this is vital for managing large wounds, reducing edema, and promoting granulation tissue.
4. Internal Fixation: If a fracture is present, orthopedic stabilization is required to prevent further shearing of the soft tissue.

Pharmacotherapy

• Prophylactic Antibiotics: Broad-spectrum coverage is initiated immediately, typically targeting Staphylococcus and Streptococcus species.
• Anticoagulation: Patients are often at high risk for Deep Vein Thrombosis (DVT) due to immobility and vascular trauma.
• Analgesia: Multimodal pain management, often requiring nerve blocks or systemic opioids during the acute phase.

Long-term Prognosis and Rehabilitation

Recovery from a degloving injury is a marathon, not a sprint. Patients must be prepared for multiple surgical procedures, including secondary revisions, scar management, and extensive physical therapy.

• Scar Contracture: The healing process often results in significant scarring, which may limit joint range of motion.
• Chronic Pain: Neuropathic pain is common due to the sheer force of the injury on peripheral nerves.
• Functional Outcomes: With aggressive physical therapy, most patients regain significant function, though sensory deficits in the affected area may persist permanently.

Frequently Asked Questions (FAQ)

1. Is a degloving injury life-threatening?
Yes, if associated with massive blood loss or systemic shock. The injury itself is a surgical emergency, but the primary focus is always on stabilizing the patient’s hemodynamic status first.

2. Can the skin be saved in a degloving injury?
In some cases, yes. If the skin is not completely devitalized, surgeons may perform a "degloving flap" procedure, where the skin is cleaned, defatted, and sutured back into place.

3. What is a Morel-Lavallée lesion?
It is a "closed" degloving injury where the skin remains intact, but the underlying tissues separate, creating a pocket that fills with blood and fluid.

4. How long does the recovery take?
Recovery time varies significantly based on the size of the injury. Minor cases may heal in weeks; extensive injuries may require months of surgical revision and rehabilitation.

5. Will I have permanent scarring?
Almost certainly. Given the nature of the trauma, scarring is a common outcome, and reconstructive plastic surgery is often required for functional and aesthetic optimization.

6. Is physical therapy necessary?
Yes. Physical therapy is mandatory to prevent joint stiffness, muscle atrophy, and to manage scar tissue contractures.

7. How do doctors determine if tissue is "dead"?
Surgeons use clinical judgment (color, capillary refill, bleeding on incision) and, in some cases, specialized dyes like indocyanine green (ICG) to assess tissue perfusion.

8. Can smoking affect the healing of a degloving injury?
Absolutely. Nicotine is a potent vasoconstrictor that significantly reduces blood flow to the skin, drastically increasing the risk of flap necrosis and wound failure.

9. What are the signs of infection I should look for?
Increased redness, warmth, foul-smelling drainage, fever, and increasing pain are all red flags that require immediate medical attention.

10. What is the role of a plastic surgeon in this injury?
Plastic surgeons are experts in soft tissue reconstruction. They manage the complex wound closure, perform skin grafts or flap transfers, and optimize the aesthetic and functional outcome of the limb.

Disclaimer: This information is for educational purposes and does not substitute professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.